Of course, weight loss supplements shouldn't be the first port of call and, before choosing to start taking any of them, it's ...

A Stanford-led team discovered a new ketosis pathway involving BHB-amino acids, shedding light on its effects like appetite ...

The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep ...

Weight loss drugs Bariatric surgery (weight loss surgery) Why is it so hard to lose weight and keep it off? Obesity is a ...

Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...

On its own, obesity can cause acute ailments, including breathlessness and back pain. Worse, it often leads to other chronic ...

This e-seminar, "Weight of Evidence approach in food authenticity - what is it and when to use it?" is based on a "Toolkit to Support Weight of Evidence Approaches for Food Authenticity Investigations ...

A new analysis estimates that losing as little as 5% weight can lead to substantial savings in health care costs elsewhere.

Competitor Novo Nordisk, the maker of Wegovy, has announced plans to bring its weight-loss drug to India by 2026. Analysts estimate the global obesity drug market could surpass $100 billion within the ...

Against this backdrop, could Lilly beat rivals in the weight loss market in 2025? Evidence is piling up, and it's pointing to one answer in particular. Before we get to that, though, let's take a ...

Not in her tool kit: The weight loss drug du jour. "My doctor chased me for like two years and I was like, 'No, I'm afraid of it. I already have thyroid problems,'" she explained on a May 2024 ...

End of carousel If confirmed, Oz would take over two of the largest taxpayer-funded programs just as pharmaceutical companies are lobbying the government to cover the cost of weight-loss drugs.